Technology News and Research

RSS

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".

31 Aug 2010

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

31 Aug 2010

TPP and University of Edinburgh collaborate on development of novel pre-clinical intellectual property

TPP Global Development Ltd (TPP) announced an agreement with the University of Edinburgh to collaborate on the development of novel pre-clinical intellectual property originated within the University.

31 Aug 2010

A-Life Medical ranked #2513 on 2010 Inc. 500|5000 list of fastest-growing, private companies

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today it has been included in the 2010 Inc. 500|5000 list of the fastest-growing, private companies in America. A-Life Medical ranked 2513 in its inaugural appearance on the list.

31 Aug 2010

UBC researchers lead development of new 'toolbox of MiniPromoters' for gene research and therapy

University of British Columbia researchers have led the development of a new "toolbox of MiniPromoters" for research and future therapies on brain, spinal cord and eye function.

31 Aug 2010

Advanced Life Sciences scientific publication demonstrates triterpenoids' potential as anticancer agents

Advanced Life Sciences Holdings, Inc.,a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the publication of a research paper in the journal Bioorganic and Medicinal Chemistry Letters that reports data using the Company's core triterpenoid platform technology in the discovery and development of new cancer therapeutic agents.

31 Aug 2010

SCOLR Pharma signs sales support agreement with Emerson Group

SCOLR Pharma, Inc. today announced that it has signed an agreement with The Emerson Group to provide sales support for the Company's new line of extended-release nutritional and over-the-counter drug products.

31 Aug 2010

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Bioheart, Inc., The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education. The Foundation aims to promote basic and applied knowledge, processes and cell therapies.

31 Aug 2010

Biotage launches new Resolux line of HPLC columns optimized for peptide purification

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, has launched a new range of HPLC columns optimized for peptide purification. The Resolux™ line was introduced during the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and will be premiered at the 31st European Peptide Symposium on September 5th in Copenhagen, Denmark.

31 Aug 2010

InSightec's ExAblate Robotic Acoustic Surgery system used for prostate cancer treatment

InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.

31 Aug 2010

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.

31 Aug 2010

Salmonella contamination drives retail sales of pasteurized shell eggs

Consumer demand for safe eggs has driven retail sales of pasteurized shell eggs up by more than 50% since Aug. 16 when the Food and Drug Administration (FDA) recommended their use to prevent illness from egg-related Salmonella Enteritidis, announced National Pasteurized Eggs (NPE).

31 Aug 2010

Detroit Medical Center's system-wide EMR helps save over $5 million in costs

The Detroit Medical Center (DMC) achieved significant improvements in patient safety and quality of care, while also saving more than $5 million in costs last year, thanks to efficiencies created by its system-wide Electronic Medical Record (EMR). This system manages nearly all of the DMC's patient health information via new computer-based technology.

31 Aug 2010

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

As one of the leading medical centers in the U.S. diagnosing and treating twin-to-twin transfusion syndrome (TTTS), Texas Children's Fetal Center is proud to announce the successful completion of its 200th TTTS laser ablation surgery.

31 Aug 2010

Advanced Cell Technology updates transdifferentiation plans to enhance regenerative medicine

Advanced Cell Technology, Inc. provides an update today on its plans to utilize its transdifferentiation platform to enhance regenerative medicine.

31 Aug 2010

Amsterdam Molecular first half 2010 net loss in line with last year

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2010.

31 Aug 2010

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.

31 Aug 2010

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

NEC Corporation and privately held SomaLogic, Inc. announced today that they have signed an agreement to explore aptamer related businesses in the life sciences and healthcare markets. In addition, NEC announced that it has made an equity investment in SomaLogic in support of a long-term strategic relationship between the two companies.

31 Aug 2010

Sutter Health collaborates with iTriage

Consumers can check health symptoms, look up health conditions and now find detailed information about doctors, hospitals, emergency rooms and medical clinics in the Sutter Health network via the free mobile health care application – iTriage.

31 Aug 2010

Forensic Fluids Laboratories ranked #167th on Inc. 500 fastest growing companies list

Forensic Fluids Laboratories Inc., a leading provider of oral fluid drug testing, today announced that the company was named to the prestigious Inc. 500 list, a list of the most entrepreneurial and fastest growing companies in the United States. Forensic Fluids Lab was number 167 on the general list, number 10 in health care, number 2 in Michigan, and number 20 for women-owned.

31 Aug 2010

Technology News and Research

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

International Symposium to explore Hybrid approach for congenital heart disease

TPP and University of Edinburgh collaborate on development of novel pre-clinical intellectual property

A-Life Medical ranked #2513 on 2010 Inc. 500|5000 list of fastest-growing, private companies

UBC researchers lead development of new 'toolbox of MiniPromoters' for gene research and therapy

Advanced Life Sciences scientific publication demonstrates triterpenoids' potential as anticancer agents

SCOLR Pharma signs sales support agreement with Emerson Group

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Biotage launches new Resolux line of HPLC columns optimized for peptide purification

InSightec's ExAblate Robotic Acoustic Surgery system used for prostate cancer treatment

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

Salmonella contamination drives retail sales of pasteurized shell eggs

Detroit Medical Center's system-wide EMR helps save over $5 million in costs

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

Advanced Cell Technology updates transdifferentiation plans to enhance regenerative medicine

Amsterdam Molecular first half 2010 net loss in line with last year

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

Sutter Health collaborates with iTriage

Forensic Fluids Laboratories ranked #167th on Inc. 500 fastest growing companies list

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News